Gambini Brasil proudly celebrates its first two years of history, marked by steady growth, innovation and an extremely positive reception from the Brazilian market. Although it was already established, operations truly accelerated in July, 2025, marking the beginning of a journey of concrete results and consolidation in the tissue sector.

In this short timespan, the company has already demonstrated significant results: four projects have been successfully delivered to the Brazilian market, reflecting not only its technical expertise, but also its commitment to quality, efficiency and innovation. Meanwhile, four additional projects – currently in production – strengthen customer confidence in Gambini’s value proposition.

This rapid development is supported by distinctive technology and a customer-focused approach, aimed at deeply understanding the specific needs of the domestic industry. The positive reception and growing interest in the solutions offered demonstrate the company’s alignment with the needs of the Brazilian market, which is increasingly open to innovation and technological evolution.

As a significant milestone in this journey, Gambini Brasil is preparing to deliver its first line entirely manufactured in Brazil by the end of this year. This milestone will be celebrated with an Open House, during which the TouchMax technology will be presented to the market: a solution designed to raise the standards of quality, efficiency and performance in the tissue industry.

The company also takes this opportunity to express its sincere thanks to all the customers, partners and collaborators who have believed and continue to believe in its work. The Brazilian market’s welcoming spirit, support and collaboration have been crucial in turning challenges into tangible results and projects into reality.

With a path already marked by real achievements and a clear vision for the future, Gambini Brasil remains committed to promoting innovation, breaking down technological barriers and actively contributing to the development of the country’s tissue sector.